院前晶体液复苏:实践差异与临床结局的关联
本研究利用Pragmatic, Randomized Optimal Platelet and Plasma Ratios试验数据集(n=680),将患者按院前晶体液量分为<1,000 mL组和≥1,000 mL组,比较初始实验室值和结局。院前晶体液量中位数0.3 L(四分位距0-0.9 L),院前时间和入组中心分别解释R²=0.2和0.54的变异。≥1,000 mL组INR、PT、PTT和碱缺失更高,红细胞压积和血小板更低;ARDS比例21% vs 12%(P<0.01),AKI率23% vs 23%(P=0.9)。多变量回归显示每500 mL院前晶体液与INR和PTT升高、红细胞压积和血小板降低相关(P<0.05),并与ARDS风险增加和AKI风险降低相关(P<0.05)。
要点
- 院前晶体液量与院前血流动力学、插管、GCS和ISS相关性弱(0.008≤R²≤0.09),院前时间和入组中心解释更多变异(R²=0.2和0.54)。
- 与<1,000 mL组相比,≥1,000 mL组INR、PT、PTT和碱缺失更高,红细胞压积和血小板更低。
- ≥1,000 mL组ARDS比例21% vs <1,000 mL组12%(P<0.01),AKI率两组均为23%(P=0.9)。
- 每500 mL院前晶体液与INR和PTT升高、红细胞压积和血小板降低相关(P<0.05)。
- 每500 mL院前晶体液与ARDS风险增加和AKI风险降低相关(P<0.05)。
适用人群与场景
- 纳入Pragmatic, Randomized Optimal Platelet and Plasma Ratios试验数据集的创伤患者(n=680)。
- 按院前晶体液量分为<1,000 mL组和≥1,000 mL组。
研究设计与关键结果
- 研究类型:利用Pragmatic, Randomized Optimal Platelet and Plasma Ratios试验数据集的二次分析;样本量n=680。
- 院前晶体液量中位数0.3 L(四分位距0-0.9 L)。
- 院前血流动力学、插管、GCS和ISS与院前晶体液量相关性弱(0.008≤R²≤0.09);院前时间和入组中心解释的变异R²分别为0.2和0.54。
- 与<1,000 mL组相比,≥1,000 mL组INR、PT、PTT和碱缺失更高,红细胞压积和血小板更低。
- 主要结局ARDS:≥1,000 mL组21% vs <1,000 mL组12%(P<0.01)。
- AKI率:≥1,000 mL组23% vs <1,000 mL组23%(P=0.9)。
- 多变量回归:每500 mL院前晶体液与INR和PTT升高、红细胞压积和血小板降低相关(P<0.05);与ARDS风险增加和AKI风险降低相关(P<0.05)。
证据类型、等级与局限
- 证据类型:基于随机对照试验数据集的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 院前晶体液输注与院前血流动力学和损伤特征相关性弱,提示当前院前晶体液实践存在差异。
- 增加院前晶体液量与更严重的贫血、凝血病和ARDS风险增加相关,但可能对AKI有保护作用(作者结论)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Introduction: Although resuscitation guidelines for injured patients favor blood products, crystalloid resuscitation remains a mainstay in prehospital care. Our understanding of contemporary prehospital crystalloid (PHC) practices and their relationship with clinical outcomes is limited. Methods: The Pragmatic, Randomized Optimal Platelet and Plasma Ratios trial data set was used for this investigation. We sought to identify factors associated with PHC volume variation and hypothesized that higher PHC volume is associated with worse coagulopathy and a higher risk of acute respiratory distress syndrome (ARDS) but a lower risk of acute kidney injury (AKI). Subjects were divided into groups that received <1,000 mL PHC (PHC<1,000) and ≥1,000 mL PHC (PHC≥1,000); initial laboratory values and outcomes (ARDS and AKI risk) were summarized with medians and interquartile ranges or percentages and compared using Wilcoxon rank-sum tests and chi-square tests. The primary outcome was ARDS risk. Multivariable regression was used to characterize the association of each 500 mL aliquot of PHC with initial laboratory values and clinical outcomes. Results: PHC volume among study subjects (n = 680) varied (median, 0.3 L; interquartile range, 0-0.9 L) with weak associations demonstrated among prehospital hemodynamics, intubation, Glasgow Coma Score, and Injury Severity Score (0.008 ≤ R2 ≤ 0.09); prehospital time and enrollment site explained more variation in PHC volume with R2 values of 0.2 and 0.54, respectively. Compared with PHC<1,000, PHC≥1,000 had higher INR, PT, PTT, and base deficit and lower hematocrit and platelets. The proportion of ARDS in the PHC≥1,000 group was higher than PHC<1,000 (21% vs. 12%, P < 0.01), whereas the rate of AKI was similar between groups (23% vs. 23%, P = 0.9). In regression analyses, each 500 mL of PHC was associated with increased INR and PTT, and decreased hematocrit and platelet count (P < 0.05). Each 500 mL of PHC was associated with increased ARDS risk and decreased AKI risk (P < 0.05). Conclusion: PHC administration correlates poorly with prehospital hemodynamics and injury characteristics. Increased PHC volume is associated with greater anemia, coagulopathy, and increased risk of ARDS, although it may be protective against AKI.
参考来源
- Weykamp MB, Stern KE, Brakenridge SC, et al. PREHOSPITAL CRYSTALLOID RESUSCITATION: PRACTICE VARIATION AND ASSOCIATIONS WITH CLINICAL OUTCOMES. Shock. 2022. PMID: 36703275. doi:10.1097/SHK.0000000000002039
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。